Fecal Microbiota Transplantation in Females With Anorexia Nervosa
Key facts
- Who runs it
- Andreas Munk Petersen
- Where
- Denmark2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Started
- 16 Nov 2026
- Expected to end
- 31 Dec 2029
- Type of study
- Interventional, 2 groups
- Treatments tested
- Fecal Microbiota Transplantation Capsule
- Placebo Capsule(s)
- Record updated
- 16 October 2026
Who can take part
- Age
- 15 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
Show the full registry criteria (16)Hide the full registry criteria
Who can take part
- Female sex
- Age ≥15 years
- Diagnosis of AN according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) which includes BMI<18.5 or equivalent in adolescents
- Ability to read and speak Danish
- Ability to swallow study capsules
- Provision of voluntary written informed consent prior to any study-specific procedures (and, for participants aged 15-17 years, written parental/legal guardian consent and participant assent in accordance with Danish regulations)
- Must have access to a standalone household freezer (Not in the freezer compartment of a refrigerator)
Who cannot take part
- Known inflammatory bowel disease, colorectal cancer, or other clinically significant chronic gastrointestinal disorder
- Current alcohol or substance use disorder
- Known food allergy to E133 and E150c
- Age <15 years
- Male sex
- Current use of laxatives
- Any somatic comorbidity that requires current medical treatment
- Systemic antibiotic treatment within the past 3 months
- Pregnancy or breastfeeding
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Anorexia nervosa
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn whether fecal microbiota transplantation (FMT) can change the gut microbiome and improve health outcomes in females with anorexia nervosa. FMT involves transferring microorganisms from the stool of a carefully screened healthy donor to the intestine of another person. In this study, FMT will be given as capsules that are swallowed by the participants.
Read full original descriptionShow less
The main questions the study aims to answer are:
* Does repeated treatment with FMT change the gut microbiome in females with anorexia nervosa? * Does FMT improve symptoms and other health outcomes related to anorexia nervosa? * How does FMT affect gastrointestinal function, including bowel habits and gut transit time in females with anorexia nervosa? * What medical problems or side effects do the participants experience during the study?
Researchers will compare FMT capsules with placebo capsules to see whether FMT affects the gut microbiome, gastrointestinal function, and symptoms related to anorexia nervosa. Placebo capsules are similar to the FMT capsules but do not contain donor fecal material.
Participants will:
* Receive five weekly FMT treatments and five weekly placebo treatments * Be randomly assigned to receive either FMT followed by placebo or placebo followed by FMT * Attend four study visits for clinical assessments and follow-up * Provide stool and blood samples at the study visits * Complete questionnaires about eating disorder symptoms, gastrointestinal symptoms, and general health * Provide information about bowel habits and other aspects of gastrointestinal function
Neither the participants nor the study staff will know which treatment is being given during each treatment period. The study will include females aged 15 years or older with anorexia nervosa.
The study will help researchers better understand the relationship between the gut microbiome and anorexia nervosa and whether changing the gut microbiome with FMT could potentially be a future treatment approach.
The 2 groups in the trial
- ATreatment being tested
FMT week 1-5 → placebo week 6-10
Treatment: Fecal Microbiota Transplantation Capsule and Placebo Capsule(s)
- BTreatment being tested
Placebo week 1-5 → FMT week 6-10
Treatment: Fecal Microbiota Transplantation Capsule and Placebo Capsule(s)
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized, Double-Blind, Placebo-Controlled Crossover Study of Fecal Microbiota Transplantation in Females With Anorexia Nervosa
- Criteria questions
- Built from NCT07877675, who can take part
- Record updated
- 16 October 2026